Le Lézard48m
TuHURA Biosciences, Inc. Enters into Definitive Merger Agreement to Acquire Kineta, Inc.
Through the combination of unique epitope binding and an optimized IgG1 Fc region ... including TuHURA's Current Report on Form 8-K filed with the SEC on October 21, 2024. Information about Kineta's ...